Rating History for Seelos Therapeutics (SEEL) by Roth/MKM
Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
---|---|---|---|---|---|---|---|
9/27/2021 | Jonathan Aschoff | Upgrade | Buy (Neutral) |
8.00 (2.50) |
2.09 (0.33) |
-84.21% | Details |
Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
---|---|---|---|---|---|---|---|
9/27/2021 | Jonathan Aschoff | Upgrade | Buy (Neutral) |
8.00 (2.50) |
2.09 (0.33) |
-84.21% | Details |